Colcher D - Search Results

1

Pharmacokinetics and biodistribution of genetically engineered antibodies.

Batra SK, Jain M, Wittel UA, Chauhan SC, Colcher D. Batra SK, et al. Among authors: colcher d. Curr Opin Biotechnol. 2002 Dec;13(6):603-8. doi: 10.1016/s0958-1669(02)00352-x. Curr Opin Biotechnol. 2002. PMID: 12482521 Review.

2

The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.

Wittel UA, Jain M, Goel A, Chauhan SC, Colcher D, Batra SK. Wittel UA, et al. Among authors: colcher d. Nucl Med Biol. 2005 Feb;32(2):157-64. doi: 10.1016/j.nucmedbio.2004.11.003. Nucl Med Biol. 2005. PMID: 15721761

3

Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.

Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Chauhan SC, et al. Among authors: colcher d. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):264-73. doi: 10.1007/s00259-004-1664-0. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791435

4

Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors.

Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D, Batra SK. Jain M, et al. Among authors: colcher d. Cancer Res. 2005 Sep 1;65(17):7840-6. doi: 10.1158/0008-5472.CAN-05-0662. Cancer Res. 2005. PMID: 16140953

5

Single-chain antibodies in pancreatic cancer.

Colcher D, Pavlinkova G, Beresford G, Booth BJ, Batra SK. Colcher D, et al. Ann N Y Acad Sci. 1999 Jun 30;880:263-80. doi: 10.1111/j.1749-6632.1999.tb09531.x. Ann N Y Acad Sci. 1999. PMID: 10415872 Review.

6

Effects of genetic engineering on the pharmacokinetics of antibodies.

Colcher D, Goel A, Pavlinkova G, Beresford G, Booth B, Batra SK. Colcher D, et al. Q J Nucl Med. 1999 Jun;43(2):132-9. Q J Nucl Med. 1999. PMID: 10429508 Review.

7

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.

Pavlinkova G, Beresford GW, Booth BJ, Batra SK, Colcher D. Pavlinkova G, et al. Among authors: colcher d. J Nucl Med. 1999 Sep;40(9):1536-46. J Nucl Med. 1999. PMID: 10492377 Free article.

8

Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.

Pavlinkova G, Colcher D, Booth BJ, Goel A, Batra SK. Pavlinkova G, et al. Among authors: colcher d. Cancer Immunol Immunother. 2000 Jul;49(4-5):267-75. doi: 10.1007/s002620000108. Cancer Immunol Immunother. 2000. PMID: 10941910 Free PMC article.

9

Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application.

Goel A, Colcher D, Baranowska-Kortylewicz J, Augustine S, Booth BJ, Pavlinkova G, Batra SK. Goel A, et al. Among authors: colcher d. Cancer Res. 2000 Dec 15;60(24):6964-71. Cancer Res. 2000. PMID: 11156397

10

Pharmacokinetics and biodistribution of genetically-engineered antibodies.

Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK. Colcher D, et al. Q J Nucl Med. 1998 Dec;42(4):225-41. Q J Nucl Med. 1998. PMID: 9973838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters